SCHEMBL24577218

SCHEMBL24577218

Cc1cc(C=O)sc1NC(=O)c1cnn2cc(-c3ccc(N)nc3)sc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 5/20 0.37
▸ JAK1 P23458 3/20 0.37
▸ TYK2 P29597 3/20 0.37
▸ JAK3 P52333 3/20 0.37
▸ CYP3A4 P08684 3/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ IKBKE Q14164 3/20 0.35
▸ TBK1 Q9UHD2 3/20 0.35
▸ PI4KB Q9UBF8 4/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3C2A O00443 1/20 0.34
▸ PIK3C2B O00750 1/20 0.34
▸ DYRK3 O43781 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ MAP4K2 Q12851 1/20 0.34
▸ STK17A Q9UEE5 1/20 0.34
▸ EIF2AK3 Q9NZJ5 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24577593 0.85 CYP3A4 (0.42) JAK2JAK1TYK2JAK3CYP3A4
SCHEMBL24577029 0.85 HDAC6 (0.37) JAK2JAK1TYK2JAK3CYP3A4
SCHEMBL24578249 0.76 KDM4E (0.43) CYP3A4PIK3CAIKBKETBK1PI4KB
SCHEMBL29759932 0.75 PDGFRA (0.48) CYP3A4PIK3CAIKBKETBK1PI4KB
SCHEMBL24577222 0.75 PDGFRA (0.48) CYP3A4PIK3CAIKBKETBK1PI4KB
SCHEMBL24578460 0.74 HDAC6 (0.36) JAK2JAK1TYK2JAK3IKBKE
SCHEMBL24577161 0.73 HDAC6 (0.39) JAK2JAK1TYK2JAK3CYP3A4
SCHEMBL24577081 0.71 HDAC6 (0.37) JAK2JAK1TYK2JAK3CYP3A4
SCHEMBL30809572 0.71 IKBKE (0.35) JAK2JAK1TYK2JAK3CYP3A4
SCHEMBL24577880 0.70 HDAC6 (0.36) JAK2JAK1TYK2JAK3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback